tiprankstipranks
Trending News
More News >
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
India Market

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Ratios

Compare
2 Followers

Jagsonpal Pharmaceuticals Ltd. Ratios

IN:JAGSNPHARM's free cash flow for Q1 2026 was ₹0.64. For the 2026 fiscal year, IN:JAGSNPHARM's free cash flow was decreased by ₹ and operating cash flow was ₹0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
6.07 6.22 10.42 10.42 5.97
Quick Ratio
5.59 5.64 9.63 9.63 5.22
Cash Ratio
0.38 4.97 0.67 0.67 0.40
Solvency Ratio
1.08 1.66 0.81 0.81 0.77
Operating Cash Flow Ratio
0.00 2.13 1.84 1.84 1.69
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
₹ 1.56B₹ 1.23B₹ 1.70B₹ 1.70B₹ 1.29B
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.03 0.04 0.04 0.03
Debt-to-Equity Ratio
0.06 0.04 0.05 0.05 0.04
Debt-to-Capital Ratio
0.06 0.04 0.05 0.05 0.04
Long-Term Debt-to-Capital Ratio
0.03 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.18 1.16 1.16 1.16 1.23
Debt Service Coverage Ratio
46.90 38.18 30.64 30.64 68.59
Interest Coverage Ratio
44.64 45.46 26.29 26.29 82.11
Debt to Market Cap
<0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
2.60 1.51 1.47 1.47 0.98
Net Debt to EBITDA
0.05 -2.34 -0.12 -0.12 -0.14
Profitability Margins
Gross Profit Margin
63.66%64.11%31.27%31.27%60.67%
EBIT Margin
18.80%15.98%14.68%14.68%14.82%
EBITDA Margin
22.06%19.01%15.50%15.50%15.38%
Operating Profit Margin
16.41%16.21%10.26%10.26%14.31%
Pretax Profit Margin
19.34%26.00%14.31%14.31%14.70%
Net Profit Margin
14.53%20.60%10.76%10.76%11.29%
Continuous Operations Profit Margin
14.53%20.60%10.76%10.76%11.29%
Net Income Per EBT
75.09%79.25%75.21%75.21%76.77%
EBT Per EBIT
117.90%160.41%139.55%139.55%102.73%
Return on Assets (ROA)
13.68%19.90%10.35%10.35%13.71%
Return on Equity (ROE)
17.60%23.07%11.99%11.99%16.82%
Return on Capital Employed (ROCE)
17.38%17.26%10.81%10.81%20.24%
Return on Invested Capital (ROIC)
12.97%13.59%8.08%8.08%15.47%
Return on Tangible Assets
18.83%28.74%10.35%10.35%13.70%
Earnings Yield
3.69%3.79%2.98%2.98%3.52%
Efficiency Ratios
Receivables Turnover
12.48 20.39 19.06 0.00 10.71
Payables Turnover
7.89 9.91 18.88 18.88 11.86
Inventory Turnover
6.46 6.34 9.56 9.56 4.50
Fixed Asset Turnover
34.40 30.41 22.44 22.44 9.75
Asset Turnover
0.94 0.97 0.96 0.96 1.21
Working Capital Turnover Ratio
3.34 1.70 1.32 1.32 2.22
Cash Conversion Cycle
39.51 38.58 37.98 18.83 84.36
Days of Sales Outstanding
29.25 17.90 19.15 0.00 34.09
Days of Inventory Outstanding
56.53 57.53 38.16 38.16 81.06
Days of Payables Outstanding
46.26 36.84 19.33 19.33 30.79
Operating Cycle
85.78 75.43 57.31 38.16 115.15
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 8.21 5.30 5.30 7.12
Free Cash Flow Per Share
0.00 8.16 5.26 5.26 7.07
CapEx Per Share
0.00 0.05 0.04 0.04 0.05
Free Cash Flow to Operating Cash Flow
0.00 0.99 0.99 0.99 0.99
Dividend Paid and CapEx Coverage Ratio
0.00 4.07 2.63 2.63 146.90
Capital Expenditure Coverage Ratio
0.00 158.91 141.80 141.80 146.90
Operating Cash Flow Coverage Ratio
0.00 5.99 3.93 3.93 7.77
Operating Cash Flow to Sales Ratio
0.00 0.21 0.17 0.17 0.20
Free Cash Flow Yield
0.00%3.76%4.64%4.64%6.10%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
27.10 26.40 33.53 33.53 28.41
Price-to-Sales (P/S) Ratio
4.01 5.44 3.61 3.61 3.21
Price-to-Book (P/B) Ratio
4.38 6.09 4.02 4.02 4.78
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 26.60 21.57 21.57 16.38
Price-to-Operating Cash Flow Ratio
0.00 26.43 21.42 21.42 16.27
Price-to-Earnings Growth (PEG) Ratio
-0.81 0.18 -1.97 -1.97 0.68
Price-to-Fair Value
4.38 6.09 4.02 4.02 4.78
Enterprise Value Multiple
18.23 26.28 23.17 23.17 20.72
Enterprise Value
11.32B 13.42B 7.49B 7.49B 7.54B
EV to EBITDA
18.23 26.28 23.17 23.17 20.72
EV to Sales
4.02 5.00 3.59 3.59 3.19
EV to Free Cash Flow
0.00 24.43 21.46 21.46 16.28
EV to Operating Cash Flow
0.00 24.27 21.31 21.31 16.17
Tangible Book Value Per Share
26.09 22.92 28.23 28.23 24.26
Shareholders’ Equity Per Share
38.56 35.63 28.23 28.23 24.26
Tax and Other Ratios
Effective Tax Rate
0.25 0.21 0.25 0.25 0.23
Revenue Per Share
42.94 39.90 31.44 31.44 36.14
Net Income Per Share
6.24 8.22 3.38 3.38 4.08
Tax Burden
0.75 0.79 0.75 0.75 0.77
Interest Burden
1.03 1.63 0.97 0.97 0.99
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.06 0.27 0.02 0.02 0.02
Stock-Based Compensation to Revenue
0.02 0.03 0.06 0.06 0.04
Income Quality
0.00 1.00 1.57 1.57 1.34
Currency in INR